![Emmanuelle Charpentier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emmanuelle Charpentier
Fondateur chez
ERS Genomics Ltd.
Health Technology
Profil
Emmanuelle Charpentier is the founder of CRISPR Therapeutics AG (founded in 2013), CRISPR Therapeutics, Inc. (founded in 2013), and ERS Genomics Ltd. (founded in 2014).
At ERS Genomics Ltd., she holds the title of Scientific Advisor.
Postes actifs de Emmanuelle Charpentier
| Sociétés | Poste | Début |
|---|---|---|
ERS Genomics Ltd.
 ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Fondateur | 01/01/2014 |
Anciens postes connus de Emmanuelle Charpentier
| Sociétés | Poste | Fin |
|---|---|---|
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Fondateur | - |
| CRISPR THERAPEUTICS AG | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
ERS Genomics Ltd.
ERS Genomics Ltd. BiotechnologyHealth Technology Develops biotechnology products | Health Technology |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops gene based medicines for the treatment of human diseases | Health Technology |
